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http://dx.doi.org/10.1016/j.kjms.201Abstract We report an unusual case involving a patient with myotonia. A 57-year-old man
had multisystemic symptoms including skeletal muscle weakness, atrophy and percussion
myotonia, cataract, heart involved, gastrointestinal tract symptoms, and urinary inconti-
nence. The electromyography revealed myotonic discharges. Muscle biopsy showed myopathic
features and a striking number of ring fibers. It was genetically proven that the case was not
myotonic dystrophy type 1 (DM1) or 2 (DM2). The case might be DM3 or an unusual case of
unclassified myopathy with multisystemic damage.
Copyright ª 2013, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Myotonic dystrophy (DM) is an autosomal dominant
disorder. Currently, two distinct mutations are known that
lead to the clinical syndrome of DM. Myotonic dystrophy
type 1 (DM1) is caused by an expanded CTG within 30
untranslated region in the DMPK gene on chromosome 19q
[1]. Myotonic dystrophy type 2 (DM2) is caused by an
expanded CCTG within the first intron in the zinc finger
protein 9 (ZNF9) gene on chromosome 3q [2]. DM1 and DM2
are progressive multisystem genetic disorders with several
clinical and genetic features in common. Classic DM1
is characterized by myotonia, prominent distal musclent of Neurology, Xuan Wu
umber 45 Changchun Street,
a.
net (Y.-W. Da).
hsiung Medical University. Publish
2.08.029weakness and atrophy, cataracts, cardiac abnormalities,
and other systemic features such as hypogonadism, insulin
resistance, deterioration in mental status, and hypersomia
[3,4]. DM2 shares the core features of DM1, including
weakness, myotonia, and multisystem involvement. In
contrast to DM1, however, many patients with DM2 muta-
tion present with prominent proximal muscle weakness, the
so-called proximal myotonic myopathy [3e5]. Patients
often suffer from myalgia. The histopathology of DM is
characterized by atrophy of muscle fibers and abnormali-
ties of the myonuclei. Ring fibers and sarcoplasmic masses
are usually present [6,7]. Here, we report a patient who
was diagnosed to have DM clinically and pathologically, but
CTG/CCTG was not proved genetically.
Clinical summary
A 57-year-old man presented to our clinic in 2009 with an
unsteady gait, hand stiffness, and weakness. He was ined by Elsevier Taiwan LLC. All rights reserved.
Figure 1. Brain MRI on FLAIR image showed mild white
matter degeneration.
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walking. Since age 47, he had been suffering from hand
stiffness and distal weakness in both upper and lower
extremities, and had chewing and swallowing difficulty,
blurry vision, hearing loss, and ptosis. During the past
5 months, he has experienced vomiting and urinary incon-
tinence. General physical examination revealed cataracts.
Evidence of cardiac dysrhythmia was not found. Neurolog-
ical examination revealed impaired memory, mild bilateral
ptosis, incomplete upgaze paresis and left eye abduction
paresis, slurred speech, atrophy of bilateral temporal
muscle and masseter, facial muscles weakness, moderate
neck flexor and rotational weakness, and atrophy of
bilateral sternocleidomastoid. On motor examination, his
proximal muscle strength was 5e and distal muscle strength
was 4þ according to Medical Research Council Grade, with
no muscle atrophy. Muscle tone was increased and
percussion myotonia could be elicited intermittently at
tongue and hands. Tendon reflexes were decreased and
plantar reflexes flexor. Examination of cerebellar and
sensory functions was normal. There was no family history
of neuromuscular disease.
Laboratory examinations of this patient were normal
including a complete blood count, electrolytes, blood
glucose, blood urea nitrogen, creatinine, aspartate
aminotransferase, alanine aminotransferase, thyroxine,
thyroid stimulating hormone, sedimentation rate, and
C reactive protein, and CSF was normal. ECG showed
atrioventricular delay and an elongated QT interval. The
first electromyography (EMG) demonstrated increased
insertional activity without myotonic discharges in five
muscles tested. Nerve conduction studies demonstrated
a subtle evidence of a polyneuropathy, including mildly
reduced sural and tibial nerve potential amplitude.
However, myotonic discharges were proved in four muscles
tested when the second EMG was performed 1 year later.
Brain MRI showed mild white matter degeneration without
brain atrophy (Fig. 1).
Pathological findings
An open biopsy of biceps muscle was obtained. The most
prominent histologic feature in H&E-stained sections was
a striking number of ring fibers and increased internal
nuclei (Fig. 2A). Subsarcoplasmic masses were seen. There
was a moderate to severe variation in myofiber diameter
with some angulated fibers scattered throughout the
sample. Myofiber-grouped atrophy was occasionally noted.
Ring fibers can be seen with several stains, in particular,
PAS and oxidative enzyme stains (Fig. 2B and 2C). Enzyme
histochemistry for ATPase, preincubated at pH 4.3, 4.6, and
9.4 showed a normal “checkerboard” pattern of fiber types,
with two types of fiber atrophy and a type 2 predom-
inance. Ring myofibrils showed more intensive staining
(Fig. 2D). Desmin Immunohistochemistry showed no desmin
accumulation.
Analysis of CTG/CCTG repeat expansions
To provide molecular confirmation of DM, DNA was extrac-
ted from an aliquot of the muscle biopsy that had beenstored at e70 C. Three-primed polymerase chain reaction
(TP-PCR) combined with evaluation of capillary electro-
pherograms was used to detect the trinucleotide CTG
repeats in the 30-untranslated region of the DMPK gene.
Amplification of DMPK triplet repeats was carried out using
500 ng of DNA in 25 mL reaction using two pairs of primers as
described previously [8]. A reaction volume of 25 mL con-
taining template DNA 500 ng to 1 mg per reaction, MixA
(PCR-P1P2): Primers P1* 100 nmol/L, P2 100 nmol/L; MixB
(TP-PCR): Primers P1* 100 nmol/L, P3R 100 nmol/L, P4CTG
20 nmol/L; 200 mM dNTPs, 2.5 mL reaction buffer (200 Mm
TriseHCl pH 8.4, 200 mM KCl, 20 mM MgSO4), and 0.25 mL
Trans-Taq-T with the following cycling profiledinitial
15 minutes denaturation at 95 C and 35 cycles of dena-
turation at 95 C for 1 minute, annealing at 62 C for
1 minute, extension at 72 C for 2 minutes, followed by
a 10-minute final extension step at 72 C. Amplicons were
checked by 3.5% agarose gel electrophoresis before capil-
lary electrophoresis. Amplification using primers flanking
the CTG repeat detected a single normal allele. TP-PCR
revealed CTG copy numbers 12/12. PCR was carried out
for CCTG repeats. The primers flanking the CCTG repeats
were F: TGAGCCGGAATCATACCAGT, R: GGCCTTATAACCATG
CAAAT. A 30 mL reaction volume containing 100 ng genomic
DNA, 25 pmol primers, 50 mM dNTPs, 3 mL reaction buffer
(100 Mm Tris pH 8.3, 500 mM KCl, 1.5 mM MgCl2, 0.01%
gelatin), and 1.5 U Taq (Takara) with the following cycling
profile: 3 minutes denaturation at 95 C and 35 cycles of
denaturation at 94 C for 35 seconds, annealing at 58 C for
35 seconds, extension at 72 C for 60 seconds, followed by
a 7-minute final extension step at 72 C. All thermal cycles
were run on a Gene Amp PCR 2700 (Applied Biosystems).
Amplicons were checked by 1.5% agarose gel electropho-
resis. Amplification detected two normal alleles.
Figure 2. Cryostat muscle sections: (A) H&E staining (200), showing variation in fiber size, internal nuclei, atrophic angulated
fibers, and striking ring fibers. The ring is peripheral in some ring fibers, while in others, the abnormally oriented myofibrils cross
through the body of the muscle fiber to produce bizarre forms (arrows). (B) PAS staining (1000), ring myofibrils show the striations
in the peripheral zone in which the myofibrils are at 90 to those in the center of the fiber. (C) NADH and (D) Myosin ATPase staining,
pH 9.4 (200), ring myofibrils show more intensive staining than the rest of the fibers.
Figure 3. FISH combined with immunofluorescence for
muscleblind (red) in patient’s muscle shows a speckled distri-
bution of muscleblind (1000).
174 Y.-W. Da et al.Fluorescence in situ hybridization-
immunofluorescence
Open biopsy of biceps muscle was obtained and prepared
for frozen sections as described by Dubowitz and Sewry [7].
Fluorescence in situ hybridization (FISH) was performed on
frozen sections (6 mm) using a (CAG)7-Texas Red-labeled
RNA probe (complementary to CUG repeats) as described
previously [9]. FISH was also combined with immunofluo-
rescence (FISH-IF) as described previously [10]. FISH-IF for
muscleblind-1 (MBNL1) was used for detecting nuclear foci.
The result showed a speckled distribution of muscleblind-1
in the nucleus and no nuclear foci (Fig. 3), which further
proves that the patient is not DM1 or DM2.
Discussion
Myotonic disorders include the DMs and nondystrophic
myotonias. DM is the most common myotonic disorder in
adults. Clinical diagnosis of DM can be easily made by the
combination of myotonia and the characteristic pattern of
muscle wasting and weakness. Patients usually have cranial
muscle wasting/weakness and limb weakness. The small
temporalis muscles, ptosis, and a long, lean face produce
a characteristic facial appearance. Swallowing may be
impaired early in the disease. Diaphragm, intercostals
muscles, intrinsic muscles in hands, quadriceps, and
external ocular muscles are often involved [11,12]. Mental
impairment have been described [11]. The manifestations
outside of the nervous system are also characteristic and
include frontal balding, cataracts, and cardiacabnormalities, insulin resistance, and other multisystemic
features [13]. The histopathology of DM is characterized by
multiple internal nuclei, together with variability in the
size of fibers, fibrosis, and architectural changes [13e16].
Ring fibers and sarcoplasmic masses are usually present.
The nondystrophic myotonias are pure skeletal muscle
diseases without the involvement of the heart, brain, eye,
or other tissues. Myotonia can be dramatic and sometimes
disabling. Emotional surprises, cold, potassium, or exercise
are potential triggers for myotonia. Muscle weakness and
wasting are not prominent.
Our patient had multisystemic symptoms, including
skeletal muscle weakness and atrophy, cataract, heart
A case mimicking DM 175involved, gastrointestinal tract symptoms, urinary inconti-
nence, and impaired memory. Muscle pathology revealed
characteristic changes of DM except for a large number of
ring fibers. As we know, ring fibers can be seen in most DM
cases, but are not specific changes. They can also be seen in
over half the cases of limb girdle dystrophy and occasionally
in desmin myopathy [17]. Desmin immunohistochemistry
showed no desmin accumulation in this case. The patient
was diagnosed to have DM clinically and pathologically.
However, the following particular points in the patient
should be noted. First, this patient had no family history of
this condition. Second, percussion myotonia could be eli-
cited intermittently at tongue and hands, but no myotonic
discharges were found in five muscles tested when the first
EMG was performed. Milone et al. [18] and Meuth et al. [19]
found a similar phenomenon. Milone et al. described a case
of genetically proven DM2 in a 61-year-old woman who
demonstrated no clinical or electrical myotonia. Meuth
et al. described a patient with intermittent percussion
myotonia at the arms, but no myotonic discharges, similar
to our patient. However, myotonic discharges were found in
four muscles tested when the second EMG was done 1 year
later. The reason is uncertain. Third, although ring fibers
are usually present in DM, too much abundant ones are
rarely seen. Moreover, their morphology is different. The
ring is peripheral in some ring fibers while in others, the
abnormally oriented myofibrils cross through the body of
the muscle fiber to produce bizarre forms [7]. This gives the
appearance that a part of ring fiber is within a normal
muscle fiber (Fig. 2A), which is not always seen in ring
fibers. Most importantly, gene tests for DM1 and DM2 were
negative and no nuclear foci of muscleblind proteins were
found by FISH-IF. Muscleblind proteins should localize to the
nuclear foci in both DM1 and DM2 [9]. These results proved
that the case might be DM3 or an unusual case of unclas-
sified myopathy with multisystemic damage.
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